Knights of Columbus Asset Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84K | Sell |
232
-84
| -27% | -$28.8K | ﹤0.01% | 362 |
|
|
2026
Q1 | $111K | Sell |
316
-964
| -75% | -$344K | 0.01% | 362 |
|
|
2025
Q4 | $419K | Sell |
1,280
-249
| -16% | -$79K | 0.02% | 319 |
|
|
2025
Q3 | $431K | Buy |
1,529
+1,445
| +1,720% | +$419K | 0.02% | 299 |
|
|
2025
Q2 | $23.5K | Sell |
84
-11
| -12% | -$3.12K | ﹤0.01% | 351 |
|
|
2025
Q1 | $29.6K | Sell |
95
-25
| -21% | -$7.38K | ﹤0.01% | 337 |
|
|
2024
Q4 | $31.3K | Sell |
120
-1,182
| -91% | -$351K | ﹤0.01% | 342 |
|
|
2024
Q3 | $420K | Buy |
1,302
+133
| +11% | +$43.5K | 0.03% | 276 |
|
|
2024
Q2 | $365K | Buy |
1,169
+430
| +58% | +$126K | 0.02% | 312 |
|
|
2024
Q1 | $210K | Sell |
739
-727
| -50% | -$213K | 0.02% | 315 |
|
|
2023
Q4 | $422K | Sell |
1,466
-35
| -2% | -$9.54K | 0.03% | 285 |
|
|
2023
Q3 | $403K | Buy |
1,501
+32
| +2% | +$7.99K | 0.04% | 277 |
|
|
2023
Q2 | $326K | Sell |
1,469
-662
| -31% | -$154K | 0.03% | 291 |
|
|
2023
Q1 | $515K | Sell |
2,131
-53,048
| -96% | -$13M | 0.05% | 269 |
|
|
2022
Q4 | $14.5M | Sell |
55,179
-13,642
| -20% | -$3.66M | 1.5% | 8 |
|
|
2022
Q3 | $15.5M | Buy |
68,821
+996
| +1% | +$241K | 1.58% | 4 |
|
|
2022
Q2 | $16.5M | Buy |
67,825
+22,219
| +49% | +$5.44M | 1.65% | 4 |
|
|
2022
Q1 | $11M | Buy |
45,606
+43,037
| +1,675% | +$9.89M | 0.94% | 14 |
|
|
2021
Q4 | $578K | Buy |
2,569
+800
| +45% | +$169K | 0.05% | 246 |
|
|
2021
Q3 | $376K | Sell |
1,769
-1,297
| -42% | -$299K | 0.03% | 261 |
|
|
2021
Q2 | $747K | Buy |
3,066
+1,119
| +57% | +$275K | 0.07% | 234 |
|
|
2021
Q1 | $484K | Sell |
1,947
-637
| -25% | -$152K | 0.05% | 266 |
|
|
2020
Q4 | $594K | Buy |
2,584
+2
| +0.1% | +$461 | 0.06% | 269 |
|
|
2020
Q3 | $656K | Sell |
2,582
-2,968
| -53% | -$735K | 0.08% | 255 |
|
|
2020
Q2 | $1.31M | Sell |
5,550
-164
| -3% | -$37.4K | 0.16% | 208 |
|
|
2020
Q1 | $1.16M | Sell |
5,714
-804
| -12% | -$176K | 0.15% | 217 |
|
|
2019
Q4 | $1.57M | Buy |
6,518
+1,888
| +41% | +$416K | 0.14% | 261 |
|
|
2019
Q3 | $896K | Buy |
+4,630
| New | +$889K | 0.34% | 87 |
|
|
2018
Q4 | – | Sell |
-5,200
| Closed | -$1.08M | – | 136 |
|
|
2018
Q3 | $1.08M | Buy |
5,200
+1,000
| +24% | +$197K | 0.43% | 72 |
|
|
2018
Q2 | $775K | Sell |
4,200
-400
| -9% | -$70.8K | 0.38% | 77 |
|
|
2018
Q1 | $784K | Buy |
4,600
+2,200
| +92% | +$404K | 0.36% | 75 |
|
|
2017
Q4 | $417K | Hold |
2,400
| – | – | 0.27% | 82 |
|
|
2017
Q3 | $447K | Hold |
2,400
| – | – | 0.3% | 84 |
|
|
2017
Q2 | $413K | Hold |
2,400
| – | – | 0.29% | 86 |
|
|
2017
Q1 | $394K | Buy |
+2,400
| New | +$399K | 0.28% | 89 |
|
Other funds holding AMGN
Knights of Columbus Asset Advisors's AMGN Position: Q2 2026 in Review
Knights of Columbus Asset Advisors reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $28.8K and leaving 232 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #362.
Knights of Columbus Asset Advisors first reported a position in AMGN in Q1 2017 and has held it in 35 quarters since. The position peaked at $16.5M in Q2 2022. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Knights of Columbus Asset Advisors held 232 shares of Amgen worth $84K as of Q2 2026.
- Knights of Columbus Asset Advisors sold 84 Amgen shares in Q2 2026, an estimated $28.8K.
- Amgen made up ﹤0.01% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #362 holding.
- Knights of Columbus Asset Advisors first reported a position in Amgen in Q1 2017 and has held it in 35 quarters since.
- Knights of Columbus Asset Advisors's Amgen position peaked at $16.5M in Q2 2022.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.